Pfizer shamed with $2.3bn fine for marketing fraud | Pharmafile
The US government has imposed a $2.3 billion fine on Pfizer for a string of offences including illegal off-label prescribing and bribery of officials. The fine represents the country’s biggest ever fraud settlement against a pharmaceutical company, and covers criminal and civil charges. The US Department of Justice announced the …
